5.50
+0.12(+2.23%)
Currency In USD
| Previous Close | 5.38 |
| Open | 5.47 |
| Day High | 5.6 |
| Day Low | 5.26 |
| 52-Week High | 7.54 |
| 52-Week Low | 3.93 |
| Volume | 1.05M |
| Average Volume | 835,623 |
| Market Cap | 282.03M |
| PE | 8.59 |
| EPS | 0.64 |
| Moving Average 50 Days | 6.14 |
| Moving Average 200 Days | 5.8 |
| Change | 0.12 |
If you invested $1000 in Abeona Therapeutics Inc. (ABEO) 10 years ago, it would be worth $57.89 as of October 21, 2025 at a share price of $5.5. Whereas If you bought $1000 worth of Abeona Therapeutics Inc. (ABEO) shares 5 years ago, it would be worth $177.42 as of October 21, 2025 at a share price of $5.5.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Abeona Therapeutics® Appoints James A. Gow, MD, MBA, MS, MHCM, as Senior Vice President, Head of Clinical Development & Medical Affairs
GlobeNewswire Inc.
11 hours ago
CLEVELAND, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a commercial-stage biopharmaceutical company developing cell and gene therapies for serious diseases, today announced the appointment of James A. Gow, MD, MBA, MS
Abeona Therapeutics® Announces ABO-503 Gene Therapy for X-linked Retinoschisis (XLRS) Selected by FDA for Rare Disease Endpoint Advancement (RDEA) Pilot Program
GlobeNewswire Inc.
Oct 13, 2025 11:30 AM GMT
RDEA Pilot Program provides sponsors enhanced communication and collaboration with FDA to accelerate development of rare disease therapiesCLEVELAND, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a commercial-stage bioph
Abeona Therapeutics® and Children's Hospital Colorado Announce Newest Treatment Center for ZEVASKYN® Gene Therapy
GlobeNewswire Inc.
Oct 08, 2025 11:30 AM GMT
CLEVELAND, Ohio and AURORA, Colo., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) and Children's Hospital Colorado today announced activation of Children's Colorado as the newest Qualified Treatment Center (QTC) for ZEVAS